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Qing Liu, PhD
University of Pittsburgh, 2014
ABSTRACT: Prediction of cause-specific cumulative incidence function (CIF) is of primary
interest to clinical researchers when conducting statistical analysis involving competing risks.
The predicted CIFs need to be dynamically updated by incorporating the time-dependent
information measured during follow-up. However, dynamic prediction of the conditional
CIFs requires simultaneously updating the overall survival and the CIF while adjusting for
the time-dependent covariates and the time-varying covariate effects which is complex and
challenging. In this study, we extended the landmark Cox models to data with competing
risks, because the landmark Cox models provide a simple way to incorporate various types
of time-dependent information for data without competing risks. The resulting new models
are called landmark proportional subdistribution hazards (PSH) models. In this study, we
first investigated the properties of the Fine-Gray model under non-PSH and proposed a
robust risk prediction procedure which is not sensitive to the PSH assumption. Then, we
developed a landmark PSH model and a more comprehensive landmark PSH supermodel.
The performance of our models was assessed via simulations and through analysis of data
from a multicenter clinical trial for breast cancer patients. As compared with other dynamic
predictive models, our proposed models exhibited three advantages. First, our models are
robust against violations of the PSH assumption and can directly predict the conditional CIFs
bypassing the estimation of overall survival and greatly simplify the prediction procedure.
Second, our landmark PSH supermodel enables users to make predictions with a set of
landmark points in one step. Third, the proposed models can simply incorporate various
iv
types of time-varying information. Finally, our models are not computationally intensive
and can be easily implemented with existing statistical software.
Public Health Significance: Prognostic models for predicting the absolute risk of a patient
in having a disease are very useful in performing risk stratification and making treatment
decisions. Since the patient’s prognosis can change over time, it is necessary to update the
risk prediction accordingly. The dynamic prediction models developed in this study can
provide more accurate prognoses over the course of disease progression and will be helpful
to physicians in adopting personalized treatment regimes.
Keywords: Competing risks; cumulative incidence function; dynamic prediction; landmark
analysis; proportional subdistribution hazards; time-dependent variables; time-varying
covariate effects.
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1.0 INTRODUCTION
For data with competing risks, although much attention was given to identify the prognostic
or risk factors on cause-specific hazard rate and on the cause-specific failure probabilities,
clinicians are showing great interest in predicting absolute risk of a cause-specific failure in
the presence of competing risks.
In quantifying the likelihood of failure from a specific cause of interest, the complement of
the Kaplan-Meier estimator where competing events are treated as censored is inappropriate
and not interpretable when the main event and competing events are correlated. In contrast,
the cumulative incidence function (CIF, also referred to as sub-distribution) is more proper in
describing a cause-specific failure probability with no assumptions of dependencies between
competing events [21]. The CIF is defined as the cumulative probability that the event of
interest occurs before a given time t in a framework where a subject is exposed to multiple
causes of failure [13].
Predicting a cause-specific CIF based on a patient’s prognostic information collected at
the time of diagnosis or at the start of treatment is essential in risk stratification and in
decision-making process. To predict CIFs, the most commonly used regression procedure is
the proportional sub-distribution hazards (PSH) model proposed by Fine and Gray (1999)
[8] which is easy to implement and can yield a simple form of the estimated CIF after adjust-
ing for multiple discrete and continuous covariates. In practice, however, the proportionality
assumption of the PSH model is often violated, especially for clinical studies with long-
term follow up. When it is used on non-proportional sub-distribution hazards, the standard
PSH model will lead to biased estimates of the CIFs. In the first part of this dissertation,
we propose a simple risk prediction procedure that adopts the PSH model yet relaxes the
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PSH assumption. The procedure can yield easy and accurate predictions of CIFs without
modeling the potentially time-varying covariate effects.
With the progression of a disease, the patient’s prognosis may change as time elapse from
the initial diagnosis. Risk prediction is not only needed at baseline but also at later time
points during follow-up. For a patient who has not yet experienced any event at a certain
time point, clinicians may predict the cumulative incidence for the occurrence of event of
interest within the next w-years. To perform dynamic prediction for competing risks data
is to dynamically predict the conditional cause-specific CIF based on the patient’s disease
history and all the information available at the specific time point during follow-up. For
data containing no competing risks, van Houwelingen (2007) [31] proposed landmark dy-
namic prediction models to predict an additional w-years conditional survival probability for
a patient who is still alive at certain time points during follow-up. The proposed landmark
models can incorporate various types of time-dependent information, including the poten-
tial time-varying covariate effects, intermediate clinical events, and longitudinally measured
biomarkers simultaneously through a simple prediction model and the implementation is
not computationally intensive. In the context of dynamic prediction, the landmark models
are more advantageous and straightforward as compared with multi-state models and joint
modeling approach [32, 33]. In the second part of this dissertation, we extend the landmark
method to data with competing risks and propose landmark proportional sub-distribution
hazards model and supermodel for dynamic prediction of the conditional CIFs for data
containing competing risks.
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2.0 ROBUST PREDICTION OF CUMULATIVE INCIDENCE FUNCTION
UNDER NON-PROPORTIONAL SUBDISTRIBUTION HAZARDS
2.1 INTRODUCTION
For data containing competing risk events, the cumulative incidence function (CIF) is a
proper summary statistic describing a subject’s absolute risk of failure from a specific cause
of interest with no assumptions of dependencies between competing events. In clinical appli-
cations, prognostic models that predict CIF from a patient’s clinical and genomic information
collected at the time of diagnosis are very useful to the physicians when performing risk strat-
ifications and making decisions on treatments. For example, with accurate predictions of
the CIF of locoreginal recurrence (LRR) oncologists can optimize radiation therapy for the
breast cancer patients. The main purpose of our study is to introduce a new approach for
predicting a subject-specific CIF directly.
Similar to the Kaplan-Meier estimator, the widely used nonparametric estimator of
the CIF has its limitations in that only a few discrete and categorized continuous co-
variates can be included. In practice, the risk of LRR often depends on a number of
histological and clinical factors, such as tumor size, nodal status, surgical margin sta-
tus, histologic subtype, and vascular invasion. When physicians tailor therapy for per-
sonalized oncology interventions, it is required that regression modeling procedures in-
corporate both discrete and continuous covariates simultaneously. One approach used is
to model the cause-specific hazards for all causes separately then combine them to es-
timate the CIF of the cause of interest. The validity of this approach depends on all
cause-specific hazards being modeled correctly which is difficult to achieve in practice.
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To date, several regression procedures were used to model the cumulative incidence
probabilities directly, including the Fine-Gray model which is also a Cox-like proportional
subdistribution hazards model [8], the pseudovalue approach [15], and the direct binomial
regression model [26]. The Fine-Gray model has become the most commonly used regression
procedure, since it provides a simple explicit form of estimation for the CIF which makes
the coefficients of covariates easier to interpret.
However, the proportional subdistribution hazards (PSH) assumption of the Fine-Gray
model may not hold for all covariates, especially in studies with long-term follow-up. For
example, some studies have shown that the effect of histologic grade shows a diminishing
trend on overall survival among patients with breast cancer. Ignoring nonproportionality
could introduce bias in prediction of CIF and this could lead to a misleading conclusion.
To handle nonproportional hazards, the most straightforward approach is to fit a Fine-Gray
model by adding time-covariate interaction terms; however, an additional assumption for
the functional form of time is required. Sun et al. (2006) [30] proposed a more flexible
and general additive-multiplicative subdistribution hazards model that can be used to es-
timate fixed covariate effects parametrically and to estimate time-varying covariate effects
nonparametrically. Although this model is superior in flexibility and generalizability, the
implementation of predicting the CIF is complicated. Alternatively, Zhou et al. (2011) [37]
proposed a stratified Fine-Gray model over a set of discrete factors where the PSH assump-
tion is not satisfied. This method categorizes a continuous variable with time-varying effect
and it cannot be used to predict a CIF if data is highly stratified. Note that in each of the
aforementioned methods a goodness-of-fit test has to be performed in advance to identify
covariates that violate the PSH assumption.
For data not containing competing risks, Struthers and Kalbfleisch (1986) [29] and Xu
and O’Quigley (2000) [35] showed that the maximum partial likelihood estimator for a Cox
proportional hazards model converges to a limiting value which is a weighted average of the
true time-varying covariate effect. Van Houwelingen (2007) [31] elucidated that a simple
Cox model with additional administrative censoring at a certain time point of interest (the
horizon time, thor) can provide an approximation for the predicted survival probabilities at
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thor if the time-varying effect does not vary much over time, if the effect of covariate is small,
and if the length of the follow-up period is limited. This valid prediction model was named
the “stopped Cox model”, meaning that the model stopped at the horizon time [33].
In this study, we introduced a new approach for predicting a subject-specific CIF directly
using a method that robust to the PSH assumption. We extended the stopped Cox model
approach to the Fine-Gray model for competing risks data, therefore our model is named
“stopped proportional subdistribution hazards model” (or a “stopped PSH model”). When
applying our models, a researcher can accurately predict a CIF without constructing complex
procedures to estimate time-varying effects when the PSH assumption is violated. In order
to eliminate the impact of heavy random censoring before the horizon time thor, we further
modified the stopped PSH model by adding a weight to reduce bias.
In Section 2.2, we review the Fine-Gray PSH model and discuss its potential issues when
the PSH assumption is violated. We then present the proposed stopped and weighted stopped
PSH models. In Section 2.3, we assess the performance in prediction for the proposed models
and compare the performance with existing methods through simulations. In Section 2.4,
we apply the proposed models to predict the CIF of LRR given a set of prognostic factors
from a breast cancer treatment trial. Discussion is provided in Section 2.5.
2.2 METHODS
2.2.1 Notations and PSH Model
Let T and C be the failure and censoring time, respectively; ε ∈ {1 . . . k} be the cause of
failure; and Z be a p-dimensional vector of time-fixed covariates. Here, we assume Ci is
independent of Ti and Zi, and refer to it as random censoring. For right censored data,
we observe an independently and identically distributed quadruplet of {Xi = Ti ∧ Ci,∆i =
I(Ti ≤ Ci),∆iεi,Zi} for subject i (i = 1 . . . n). Subdistribution or CIF for failure from cause
1 is defined as F1(t;Z) = Pr(T ≤ t, ε = 1|Z). Our objective is to predict the CIF of a
subject given his or her covariate values.
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Fine and Gray (1999) [8] proposed a proportional hazards regression model for the sub-
distribution F1(t;Z). This PSH model takes the form
λ1(t;Z) = λ10(t) exp(Z
Tβ),
where the baseline subdistribution hazards λ10(t) = −d log{1 − F1(t;Z = 0)}/dt is an
unspecified, nonnegative function; and where β is a vector of unknown regression parameters.
Thus, the cumulative incidence function can be calculated as
F1(t;Z) = 1− exp
{
−
∫ t
0
λ10(u) exp(Z
Tβ) du
}
.
The regression coefficients β are estimated through a partial likelihood approach with
modified risk sets defined as R(Ti) = {j : (Tj ≥ Ti) ∪ (Tj ≤ Ti ∩ εj 6= 1)} for the ith
individual. R(Ti) includes all individuals who have not failed from the cause of interest
by time Ti. When random right censoring is present, the inverse probability of censoring
weighting (IPCW) technique [25] is applied to obtain an unbiased partial likelihood estimator
βˆPL via a weighted score function U(β) given by
U(β) =
n∑
i=1
∫ ∞
0
{
Zi −
∑
j ωj(t)Yj(t)Zj exp(Z
T
j β)∑
j ωj(t)Yj(t) exp(Z
T
j β)
}
ωi(t) dNi(t), (2.1)
where Ni(t) = I(Ti ≤ t, εi = 1), Yi(t) = I(Ti ≥ t) + I(Ti < t, εi 6= 1) and ωi(t) =
I(Ci ≥ Ti ∧ t)Gˆ(t)/Gˆ(Xi ∧ t) in which Gˆ(t) is the Kaplan-Meier estimator of the censoring
survival distribution G(t) = Pr(C ≥ t). The baseline cumulative subdistribution hazards
Λ10(t) =
∫ t
0
λ10(u) du can be estimated using a modified version of the Breslow estimator,
Λˆ10(t) =
1
n
n∑
i=1
∫ t
0
1
1
n
∑
j ωj(u)Yj(u) exp(Z
T
j βˆPL)
ωi(u) dNi(u). (2.2)
Therefore, the predicted CIF can be calculated as Fˆ1(t; z) = 1− exp
{
− exp(zT βˆPL)Λˆ10(t)
}
for an individual with covariatesZ = z at time t. It has been shown that βˆPL is consistent for
β; Λˆ10(t) uniformly converges in probability to the true baseline cumulative subdistribution
hazard value Λ10(t) on the interval [0, τ), where τ = sup{t : Pr(X ≥ t) > 0}; and Fˆ1(t; z)
uniformly converges to F1(t; z) on the same interval [8, 12].
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The PSH assumption would be violated if a subdistribution hazards ratio changes over
time. Although it is straightforward to incorporate time-varying coefficients β(t) into a PSH
model
λ1(t;Z) = λ10(t) exp{ZTβ(t)}, (2.3)
we will need to estimate the time-varying functional form β(t) in order to predict the CIF.
This could make prediction complicated, especially when there are more than one covariate
with time-varying effects. By extending the idea of stopped Cox model [33] to data with
competing risks, we investigate the prediction performance of the Fine-Gray PSH model
with additional administrative censoring at the prediction horizon time thor, when the PSH
assumption is not satisfied.
2.2.2 Stopped PSH Model
Struthers and Kalbfleisch (1986) [29] have investigated the properties of βˆPL of a Cox propor-
tional hazards (PH) model when the true model is actually accelerated failure time model.
Xu and O’Quigley (2000) [35] showed that under nonproportional hazards, the βˆPL is con-
sistent for a weighted average of true time-varying effects β(t) over time. We can also derive
similar properties of βˆPL for the PSH model when the proportionality assumption is vio-
lated. In the following sections, we suppose the true model is given by model (2.3). For
complete data and censoring-complete data where the censoring time is always observed, the
PSH model is inherited from the usual Cox PH model [8]; so that the properties derived
from the Cox model can be directly generalized to the PSH model. Thus, we mainly focus
on the situation where random right censoring is present.
Define S(r)(β, t) = 1
n
∑n
i=1 ωi(t)Yi(t)Z
⊗r
i exp(Z
T
i β) and s
(r)(β, t) = ES(r)(β, t), for r =
0, 1, 2, where the expectations are taken with respect to the true distribution of (T,C,Z).
Suppose the Andersen-Gill-type conditions (see Appendix A) hold throughout the paper, we
have the following theorem.
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Theorem 1. Under random right censoring, the partial likelihood estimator βˆPL from
the proportional subdistributional hazards model is a consistent estimator of β∗, where β∗ is
the solution to the equation
∫ ∞
0
{
s(1)(β(t), t)
s(0)(β(t), t)
− s
(1)(β, t)
s(0)(β, t)
}
s(0)(β(t), t)λ10(t) dt = 0. (2.4)
As described in Fine and Gray (1999) [8], an improper failure time T ∗, defined as T ×
I(ε = 1) + ∞ × {1 − I(ε = 1)}, has a distribution function as F1(t) for t ≤ ∞ and a
point mass at t = ∞. The subdistribution hazard λ1(t) is actually the hazard function
for T ∗. We can treat the PSH model for event time T of cause 1 as the Cox PH model
for the improper failure time T ∗. Under random censoring, we have S(r)(β, t) = S(r)∗ (β, t)
and s(r)(β, t) = s
(r)
∗ (β, t), for r = 0, 1, 2, where S(r)∗ (β, t) =
1
n
∑n
i=1 Y
∗
i (t)Z
⊗r
i exp(Z
T
i β),
s
(r)
∗ (β, t) = ES(r)∗ (β, t), Y
∗(t) = I(X∗ ≥ t), and X∗ = T ∗ ∧ C. Hence, in terms of the
improper failure time T ∗, Theorem 1 is identical to Theorem 2.1 in Struthers and Kalbfleisch
(1986) [29]. Proof of Theorem 1 can be seen in Struthers and Kalbfleisch (1986) [29].
To get an interpretable form of β∗, we need to make some transformation for equa-
tion (2.4). As discussed in Xu and O’Quigley (2000) [35], S(1)∗ (β(t), t)/S
(0)
∗ (β(t), t) can
be thought of as a conditional expectation of Z taken with respect to the empirical dis-
tribution
Y ∗i (t) exp{ZTi β(t)}∑n
j=1 Y
∗
j (t) exp{ZTj β(t)}
. Under the Andersen-Gill-type conditions (see Appendix A),
S(1)∗ (β(t), t)/S
(0)
∗ (β(t), t) converges in probability to s
(1)
∗ (β(t), t)/s
(0)
∗ (β(t), t). Then, we have
s(1)(β(t), t)
s(0)(β(t), t)
=
s
(1)
∗ (β(t), t)
s
(0)
∗ (β(t), t)
= E(Z|T ∗ = t), (2.5)
∂
∂β
(
s(1)(β, t)
s(0)(β, t)
)
β=β(t)
=
∂
∂β
(
s
(1)
∗ (β, t)
s
(0)
∗ (β, t)
)
β=β(t)
= Var(Z|T ∗ = t). (2.6)
Hence,
s(1)(β(t), t)
s(0)(β(t), t)
− s
(1)(β, t)
s(0)(β, t)
≈ {Var(Z|T ∗ = t)}T{β − β(t)}. (2.7)
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Under random censoring,
s(0)(β(t), t)λ10(t) = E[ω(t)Y (t) exp{ZTβ(t)}]λ10(t)
= E[ω(t)Y (t) exp{ZTβ(t)}λ10(t)]
= E{ω(t)Y (t)}E{λ1(t|Z)|T ≥ t} (2.8)
= {1− F1(t)}G(t)λ1(t),
where λ1(t) is the marginal subdistribution hazard and F1(t) is the marginal subdistribution.
Thus, the equation (2.4) is approximately given by
∫ ∞
0
{Var(Z|T ∗ = t)}T{β − β(t)}{1− F1(t)}G(t)λ1(t) dt = 0. (2.9)
When we add additional administrative censoring at horizon time thor and take the first-
order Taylor series approximation to the integrand of (2.9), the β∗ becomes
β∗hor ≈
∫ thor
0
{1− F1(t)}G(t)λ1(t){Var(Z|T ∗ = t)}Tβ(t) dt∫ thor
0
{1− F1(t)}G(t)λ1(t)Var(Z|T ∗ = t) dt
, (2.10)
which is similar to the approximation of β∗ in Cox model shown by van Houwelingen (2007)
[31]. If the cumulative incidence function F1(t) does not get too large; the censoring propor-
tion is not too high before thor (G(thor) ≈ 1); and the effect of a covariate is not too large
and does not vary too much over time, Var(Z|T ∗ = t) could be approximated by a constant.
Therefore, we have
β∗hor ≈
∫ thor
0
λ10(t)β(t) dt∫ thor
0
λ10(t) dt
, (2.11)
which is a weighted average of β(t) over time. Approximation (2.11) is similar to formula
(3.2) given in Xu and O’Quigley (2000) [35].
After applying the PSH model to the data up to thor, the cumulative subdistribution
hazard can be estimated by
Λˆ1(thor;Z) = exp(Z
T βˆPL)Λˆ10(thor),
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where Λˆ10(thor) is given in (2.2). Following the derivations of the approximated limiting
values of the Breslow estimated hazards for the Cox model [31], the Breslow-type subdistri-
bution baseline hazard estimate λˆ10(t) = dΛˆ10(t)/dt converges in probability to λ
∗
10(t), which
is approximated by
λ∗10(t) ≈ λ10(t) exp[E(Z|T ∗ = t)T{β(t)− β∗hor}]. (2.12)
The derivation of the approximation (2.12) is given in the Appendix B.
The corresponding limiting value of Λˆ1(thor;Z) is
Λ∗1(thor;Z) = exp(Z
Tβ∗hor)
∫ thor
0
λ∗10(t) dt,
so that Λ∗1(thor;Z) has an approximation
Λ∗1(thor;Z) ≈ exp(ZTβ∗hor)
∫ thor
0
λ10(t) exp[E(Z|T ∗ = t)T{β(t)− β∗hor}] dt. (2.13)
The true value Λ1(thor;Z) =
∫ thor
0
λ10(t) exp{ZTβ(t)} dt can be written as the form
Λ1(thor;Z) = exp(Z
Tβ∗hor)
∫ thor
0
λ10(t) exp[Z
T{β(t)− β∗hor}] dt. (2.14)
Under the conditions for yielding the approximation (2.11), the conditional distribution of Z
given T ∗ = t can be seen as stable over time, and hence, we have the following relationships
Λˆ1(thor;Z)
p→ Λ∗1(thor;Z) ≈ Λ1(thor;Z). (2.15)
Therefore, even though the proportional hazards assumption does not hold, the PSH
model with administrative censoring at thor provides approximately correct prediction of
F1(t;Z) at t = thor over the interval [0, thor], if 1−F1(t) and G(t) are close to 1 and the true
covariate effects β(t) or the subdistribution hazards ratio does not vary too much over time.
We name such a PSH model as the stopped PSH model, indicating that the PSH model
stopped at the horizon time thor.
So far, we have shown that under non-proportional hazards, the stopped PSH model
performs well on predicting the CIF. We also investigated its properties when the PSH
assumption holds. For complete data, the stopped PSH model at thor is exactly the PSH
model for data with administrative censoring, so that the model properties have been shown
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in Section 3.2 of Fine and Gray (1999) [8]. For incomplete data with random right censoring,
the stopped PSH model also applies the IPCW approach to adjust for the censoring effect
before thor. When t ≤ thor, the weight function ω(t) in stopped PSH model is the same as it
calculated via the Fine-Gray PSH model. To predict the Λˆ1(t;Z) at time thor,
Λˆ1(thor;Z) =
1
n
n∑
i=1
∫ thor
0
exp(ZT βˆPL)
1
n
∑
j ωj(u)Yj(u) exp(Z
T
j βˆPL)
ωi(u) dNi(u), (2.16)
we only need the information up to thor, because for subjects {j : Xj ≥ thor}, the risk set
at thor will not change regardless of whether they were censored, had competing events,
or were still alive. Hence, under proportional hazards, according to the properties of the
PSH model given in Fine and Gray (1999) [8], the stopped PSH model also gives reliable
prediction of F1(thor;Z) if thor is less than τ = sup{t : Pr(X ≥ t) > 0}. However, as shown
in equation (2.16), the Λˆ1(thor;Z) depends on the partial likelihood estimator βˆPL; so that
the Fˆ1(thor;Z) from the stopped PSH model may be less efficient compared to that from the
Fine-Gray PSH model, since less events are used when we calculate the βˆPL in the stopped
PSH model.
2.2.3 Weighted Stopped PSH Model
As discussed in Section 2.2.2, the limiting value β∗hor of the partial likelihood estimator βˆPL
in the stopped PSH model depends on the unknown censoring distribution G(t) through
s(0)(β(t), t). If there is a heavy censoring before thor, the approximation of β
∗
hor shown in
(2.11) will not be valid, and the limiting value of the Λˆ1(thor;Z) will not be approximately
equal to the true value. Thus, Fˆ1(thor;Z) will lose accuracy when thor is far away from the
origin. Therefore, the stopped PSH model needs to be modified in order to correct the heavy
random censoring before thor.
In the Cox model, Xu and O’Quigley (2000) [35] proposed a weighted partial likelihood
estimator whose limiting value is independent of censoring. We generalize their method to
the PSH model and derive a reweighted score equation as the form
Uw(β) =
n∑
i=1
∫ ∞
0
W (t)
{
Zi −
∑
j ωj(t)Yj(t)Zj exp(Z
T
j β)∑
j ωj(t)Yj(t) exp(Z
T
j β)
}
ωi(t) dNi(t), (2.17)
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where W (t) = Sˆ(t)/
∑n
i=1 Y
′
i (t), Sˆ(t) is the left continuous version of the Kaplan-Meier
estimator of the overall survival S(t) and Y ′i (t) = I(Xi ≥ t). The solution to equation
(2.17) is denoted as βˆw. If there is no ties, W (Xi) can be viewed as the increment of the
nonparametric estimate of the marginal cumulative incidence function F1(t) at an observed
main event time Xi. It can be verified that W (t)G(t) is approximately equal to a constant
c. Under random censoring, now we have
s(0)(β(t), t)λ10(t) = E[W (t)ω(t)Y (t) exp{ZTβ(t)}λ10(t)]
= c{1− F1(t)}λ1(t). (2.18)
Thus, the influence of censoring has been removed from s(0)(β(t), t). Following Theorem 3.2
in Lin (1991) [16] and Theorem 2 in Xu and O’Quigley (2000) [35], we have
Theorem 2. Under non-proportional PSH model (2.3), the weighted estimator βˆw con-
verges in probability to β˜, where β˜ is the unique solution to the equation∫ ∞
0
{
s(1)(β(t), t)
s(0)(β(t), t)
− s
(1)(β, t)
s(0)(β, t)
}
{1− F1(t)}λ1(t) dt = 0, (2.19)
if
∫∞
0
υ(β˜, t){1− F1(t)}λ1(t) dt > 0, where υ(β˜, t) = s(2)(β˜,t)s(0)(β˜,t) −
{
s(1)(β˜,t)
s(0)(β˜,t)
}⊗2
If we rewrite equation (2.19) in terms of T ∗, the proof of Theorem 2 could follow the
arguments in Xu (1996) [34]. It is clear that the censoring distribution G(t) is not involved
in equation (2.19); therefore, G(t) is not involved in the form of solution β˜.
Similarly, in the presence of administrative censoring at thor, applying (2.7) to equation
(2.19), then the first-order Taylor series approximation of β˜ becomes
β˜hor ≈
∫ thor
0
{1− F1(t)}λ1(t){Var(Z|T ∗ = t)}Tβ(t) dt∫ thor
0
{1− F1(t)}λ1(t)Var(Z|T ∗ = t) dt
. (2.20)
Following the same derivation in Section 2.2.2 , it can be easily shown that the limiting
value Λ˜1(thor;Z) of Λˆ1(thor;Z) calculated by βˆw is approximately equal to the true value
Λ1(thor;Z) if the variation of β(t) over time is not too large and 1 − F1(thor) is not too
far away from 1, where Λ˜1(thor;Z) takes the same approximation form as Λ
∗
1(thor;Z) does,
which was shown in (2.13), only replacing β∗ with β˜.
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Therefore, compared to the stopped PSH model, the weighted stopped PSH model not
only provides an accurate predictive cumulative incidence at thor but also remedies the impact
of the heavy censoring before thor.
2.2.4 Measure of Predictive Accuracy
To evaluate the predictive accuracy of the proposed procedures, we adapted the Brier score
which is an estimate of the mean-squared prediction errors of the predicted event probabilities
over the observed event status [11, 27]. For competing risks data, the expected Brier score
at horizon time is defined as
BSthor = E{I(T ≤ thor, ε = 1)− F1(thor;Z)}2.
In the presence of random censoring, a consistent estimator of BSthor was proposed by Schoop
et al. (2011) [27], which was applied the IPCW approach [24],
B̂Sthor =
1
n
n∑
i=1
{I(Xi ≤ thor,∆iεi = 1)− Fˆ1(thor;Zi)}2wb(Xi),
for all times thor ≤ sup{t : G(t) > 0}, where
wb(Xi) =
I(Xi ≤ thor,∆iεi 6= 0)
Gˆ(Xi−)
+
I(Xi > thor)
Gˆ(thor)
.
To quantify the improvement of predictive accuracy for the stopped PSH model compared
to the Fine-Gray PSH model under nonproportional hazards, we utilized a relative increment
of prediction errors (RIPE) by making the nonparametric estimates as a reference, i.e.,
RIPES-PSH = B̂S
S-PSH
thor
/B̂S
NP
thor
− 1.
In addition, we also measure the global prediction errors by computing the integrated Brier
scores,
IBSthor =
∫ thor
0
BSt dt,
which is estimated by using the composite trapezoidal rule [27, 33].
13
2.3 SIMULATION STUDIES
We evaluated the performance in prediction for the proposed procedures with simulated
data under both proportional and nonproportional subdistribution hazards. We compared
the Brier scores of the proposed methods to the nonparametric estimates and the PSH model.
For simplicity, only two failure types were considered. Type 1 failure was the main event of
interest, and type 2 failure indicated competing event.
For data under PSH, we generated the type 1 failure times from the subdistribution
function
F1,PSH(t;Zi) = 1− (1− p[1− exp{−(λt)α}])exp(Ziβ),
which is a two-parameter Weibull mixture distribution. Zi is a dichotomous covariate from
Bernoulli(0.5). We let (α, λ, β) = (2.2, 0.18,−1). For data under non-PSH, we created two
different sets of simulations. In the first set we let the rate parameter λ be dependent on
the covariate Zi; and the subdistribution of the main event became
F1,1stnonPSH(t;Zi) = p(1− exp[−{λ1 exp(Ziβ1)t}α1 ]).
In the second set we generated data based on
F1,2ndnonPSH(t;Zi) = 1− (1− p[1− exp{−(λ2t)α2}])exp(Ziβ21+Ziβ22t),
where the coefficient of Zi is a linear function of time. Under both non-PSH settings, we con-
sidered Zi as Bernoulli(0.5) variates and let (α1, λ1, β1, α2, λ2, β21, β22) = (3.2, 0.18,−0.8, 2.2,
0.12, 0.5, 0.01). For the second non-PSH set, we also considered Zi as a continuous vari-
able from Normal(0.5, 0.01) and let (α2, λ2, β21, β22) = (1.2, 0.12, 0.5, 0.01). For all simu-
lations, we let p = 0.3, which produced about 30% main events at Zi = 0 when there
was no censoring. We generated the type 2 failure times from an exponential distribution
Pr(Ti ≤ t|εi = 2, Zi) = 1 − exp{− exp(Ziβct)} by taking Pr(εi = 2|Zi) = 1 − Pr(εi = 1|Zi),
where βc = 0.5. Sample size of n = 500 was chosen and the data were simulated repeat-
edly; N = 1000 times. The censoring times were generated independently from a uniform
distribution which resulted in about 20% censoring.
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In the first non-PSH set, we compared the performances in prediction for CIFs obtained
from the nonparametric method, the PSH model, the proposed stopped PSH model, and the
proposed weighted stopped PSH model. In the second non-PSH set, we also fitted a PSH
model with time-varying effects by adding an interaction term of covariate Zi and a linear
function of time. The resulted CIFs were compared with that from our proposed models.
Figure 1 depicts the true and the estimated CIFs under different approaches. By comparing
the performances between models, we found that the stopped PSH model was as good as the
nonparametric method under both PSH and non-PSH scenarios in the absence of censoring,
and that the stopped PSH model shows slight bias at the late follow-up years when there was
a 20% censoring. The results showed that the bias was reduced if a weighted stopped PSH
model was used. Note that the differences in the estimated CIFs obtained from different
models diminish over time. This is because at the end of a long follow-up, the number of
events is very small and not enough to capture the differences.
We also evaluated the prediction errors for each approach by estimating the Brier scores
and used 3-fold cross-validation to correct for possible overfitting. Figure 2 shows the relative
increments of prediction errors with corresponding empirical standard deviation at horizon
time from 0 to 10 years. In the case of discrete covariate, we chose the nonparametric
estimate as a reference. In the case of continuous covariate, we chose the estimate from the
PSH model with time-covariate interactions as a reference. To examine the global prediction
accuracy over short-term and long-term periods, we calculated the cross-validated integrated
Brier score (with empirical standard deviation and the 95% confidence interval) at 5 and 10
years, respectively. The results are shown in Table 1. As expected, in both non-PSH sets
the predictive accuracy of the stopped PSH model was almost the same as that obtained
from the nonparametric method. Compare to the stopped PSH model, the weighted stopped
PSH model reduced the prediction errors further in the presence of censoring. In the second
non-PSH set, there were only minor differences in prediction errors among the stopped
PSH model, the weighted stopped PSH model, and the PSH model with time-covariate
interactions.
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Table 1: Cross-validated (3-fold) estimates for the integrated Brier scores (IBS) at thor = 5
and 10, the corresponding empirical standard deviation (SD) and empirical 95% confidence
interval.
(a) 1st non-PSH setting: Z ∼ Bernoulli (0.5)
thor = 5 thor = 10
Censoring Ave. SD 95% C.I. Ave. SD 95% C.I.
0 IBSNP 10.744 1.795 – 72.350 5.521 –
IBSPSH 11.295 1.925 – 80.143 6.186 –
IBSS-PSH 10.743 1.795 – 72.368 5.527 –
RIBSPSH/NP 5.095 2.148 (4.961, 5.228) 10.807 3.112 (10.614, 11.000)
RIBSS-PSH/NP -0.008 0.022 (-0.009, -0.007) 0.025 0.120 (0.017, 0.032)
20% IBSNP 10.784 1.965 – 72.459 6.341 –
IBSPSH 10.912 2.001 – 73.962 6.409 –
IBSS-PSH 10.785 1.965 – 72.595 6.385 –
IBSWS-PSH 10.781 1.964 – 72.492 6.353 –
RIBSPSH/NP 1.180 1.633 (1.079, 1.282) 2.098 1.827 (1.985, 2.212)
RIBSS-PSH/NP 0.003 0.185 (-0.008, 0.015) 0.186 0.633 (0.145, 0.225)
RIBSWS-PSH/NP -0.032 0.192 (-0.044, -0.020) 0.046 0.517 (0.014, 0.078)
(b) 2nd non-PSH setting: Z ∼ Bernoulli (0.5)
thor = 5 thor = 10
Censoring Ave. SD 95% C.I. Ave. SD 95% C.I.
0 IBSNP 17.532 2.585 – 98.202 6.703 –
IBSPSH.f(t) 17.577 2.590 – 98.380 6.724 –
IBSS-PSH 17.531 2.585 – 98.198 6.703 –
RIBSPSH.f(t)/NP 0.261 0.747 (0.215, 0.307) 0.180 0.263 (0.164, 0.197)
RIBSS-PSH/NP -0.005 0.021 (-0.007, -0.004) -0.004 0.062 (-0.008, 0.000)
20% IBSNP 17.548 2.785 – 98.505 7.602 –
IBSPSH.f(t) 17.516 2.777 – 98.548 7.614 –
IBSS-PSH 17.546 2.786 – 98.554 7.623 –
IBSWS-PSH 17.537 2.782 – 98.488 7.606 –
RIBSPSH.f(t)/NP -0.179 0.505 (-0.210, -0.147) 0.044 0.596 (0.007, 0.081)
RIBSS-PSH/NP -0.011 0.147 (-0.020, -0.002) 0.049 0.500 (0.018, 0.080)
RIBSWS-PSH/NP -0.064 0.146 (-0.073, -0.055) -0.017 0.461 (-0.046, 0.011)
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(c) 2nd non-PSH setting: Z ∼ Normal (0.5, 0.01)
thor = 5 thor = 10
Censoring Ave. SD 95% C.I. Ave. SD 95% C.I.
0 IBSPSH.f(t) 36.202 3.944 – 123.236 8.289 –
IBSS-PSH 36.238 3.947 – 123.301 8.294 –
RIBSS-PSH/PSH.f(t) 0.099 0.153 (0.089, 0.108) 0.053 0.059 (0.049, 0.057)
20% IBSPSH.f(t) 36.226 4.160 – 123.310 9.032 –
IBSS-PSH 36.259 4.163 – 123.352 9.031 –
IBSWS-PSH 36.250 4.162 – 123.352 9.046 –
RIBSS-PSH/PSH.f(t) 0.092 0.125 (0.084, 0.099) 0.035 0.150 (0.026, 0.044)
RIBSWS-PSH/PSH.f(t) 0.067 0.128 (0.059, 0.075) 0.074 0.151 (0.065, 0.084)
NP: the nonparametric estimates; PSH: the PSH model; PSH.f(t): the PSH model with time-covariate
interactions; S-PSH: the stopped PSH model; WS-PSH: the weighted stopped PSH model. RIBS is the
relative increment of integrated Brier scores, i.e., RIBSPSH/NP = IBSPSH/IBSNP - 1. All entries are
multiplyed by 100.
2.4 APPLICATION
To illustrate the use of our proposed methods in predicting subject-specific CIF, we used
data from the NSABP B-14 trial which was a multicenter phase III clinical trial for women
with estrogen receptor positive and historically nodes-negative primary breast cancer [10]. In
this trial, 2,892 patients were randomly assigned to receive 5 years of tamoxifen or placebo
after surgeries. Among the 2,767 clinically eligible patients whom were followed up, 286
developed locoreginal recurrence (LRR), 1,155 had other events before LRR including distant
recurrence, second primary cancers, and death; the remaining 1,326 were censored. The
median follow-up time was 6.4 years. Our main interest in this application is to predict
the cumulative probabilities of LRR given a set of prognostic factors including treatment
(tamoxifen vs. placebo), surgery type (lumpectomy plus radiation therapy [L+XRT] vs.
mastectomy), age at the time of surgery (< 50 vs. ≥ 50 years old), and tumor size ranging
from 0 to 9.8 cm with a median of 2 cm.
We began our analysis by examining the PSH assumption for each prognostic factor from
the plot of Shoenfeld-type residuals versus time. Figure 3 shows that all prognostic factors
of interest violated the PSH assumption significantly. We also assessed the PSH assumption
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Black curves: the Z = 1 group; gray curves: the Z = 0 group. True: underlying true CIFs. NP:
nonparametric method; PSH: the PSH model; PSH.f(t): the PSH model with time-covariate
interactions.
Figure 1: Predicted cumulative incidence functions (averaged over 1000 simulations) at a set
of horizon times.
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The prediction errors were cross-validated (3-fold) estimates for the Brier scores (BS). NP:
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interactions; S-PSH: the stopped PSH model; WS-PSH: the weighted stopped PSH model.
Figure 2: Relative increment of prediction errors (and their standard deviation) at horizon
time from 0 to 10.
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using the numeric goodness-of-fit test proposed by Zhou et al. (2013) [36]. The testing results
suggested significant linear covariate effects for all prognostic factors and significant quadratic
time-varying effects for treatment, surgery type, and tumor size (Table 2). By adding linear
and quadratic time interaction terms to the Fine-Gray PSH model we substantially improved
the model fit. This is depicted by the Shoenfeld-type residual plots in Figure 3.
We estimated the cumulative probabilities of LRR over time for patients with differ-
ent characteristics from four different models: the PSH model, the PSH model with time-
covariate interactions, and our two proposed models (stopped PSH and weighted stopped
PSH models). For demonstration, we selected two subgroups of patients with different sets
of characteristics: the first subgroup included younger breast cancer patients (< 50 years old
at the time of surgery) with 3 cm tumor size, received L+XRT, and treated with placebo;
the second subgroup included older patients (≥ 50 years old at the time of surgery) with 1
cm tumor size, received mastectomy, and treated with tamoxifen. Figure 4 depicts the esti-
mated predicted cumulative probabilities of LRR for the two subgroups of patients obtained
from the aforementioned four different modeling approaches. The results show that the es-
timates from our proposed models (both unweighted and weighted stopped PSH models)
agree with that obtained from the PSH model with time-covariate interactions but disagree
with that obtained from the simple PSH model. From the simple PSH model, no substantial
differences were found in the probabilities of developing LRR between the two subgroups.
We also compared the predictive capability of the four models by estimating the Brier
scores at 1, 3, 5, 7, and 9 years (Table 3). In order to quantify how much the proposed models
gained in terms of prediction accuracy, we chose the PSH model as the reference model and
assessed the relative increment (or reduction) of prediction errors for other three regression
models in comparison with the reference model (Table 3). The results show that our proposed
stopped PSH model surpasses PSH model in prediction accuracy and it also surpasses the
PSH model with time-covariate interactions. The weighted stopped PSH model also yielded
smaller prediction errors, and the stopped PSH model had the smallest prediction errors.
One possible reason for the weighted stopped PSH model not performing as well as
the stopped PSH model with this particular data is that there was only less than 10% of
the samples censored before year 10, which may lead to biased estimates of the weights.
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To account for the possible overfitting, we also computed a 3-fold cross-validated Brier
scores and the standard errors (SE), where the SE estimates were obtained from estimating
sampling distribution of the Brier scores by resampling the original dataset of size 2,767 for
B = 500 times. Because that the number of main events (developing LRR) was too small,
our proposed models and the PSH model with time-covariate interactions only showed minor
improvements in prediction accuracy and became less efficient in comparison with the simple
PSH model. An alternative strategy is to validate the performance of our models with an
external dataset that is independent of the dataset used for fitting the model.
Table 2: Goodness-of-fit test for the PSH model.
Covariates t t2 t+ t2
Treatment 0.005 0.011 0.020
Surgery type < .001 < .001 < .001
Age 0.021 0.058 0.033
Tumor size 0.017 0.020 0.066
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Table 3: Estimated Brier scores at various prediction horizon times (thor= 1, 3, 5, 7, and 9
years).
thor
1 3 5 7 9
BSPSH 0.611 3.376 4.691 5.880 6.751
BSPSH.f(t) 0.607 3.368 4.675 5.879 6.756
BSS-PSH 0.603 3.368 4.671 5.875 6.750
BSWS-PSH 0.603 3.369 4.672 5.877 6.753
RIPEPSH.f(t)/PSH -0.614 -0.230 -0.342 -0.013 0.084
RIPES-PSH/PSH -1.225 -0.224 -0.426 -0.083 -0.009
RIPEWS-PSH/PSH -1.223 -0.192 -0.401 -0.041 0.038
PSH: the PSH model; PSH.f(t): the PSH model with time-covariate interactions; S-PSH: the
stopped PSH model; WS-PSH: the weighted stopped PSH model. RIPE is the relative increment
of prediction errors where BSPSH is a reference, i.e., RIPEPSH.f(t)/PSH = BSPSH.f(t)/BSPSH - 1.
All entries are multiplyed by 100.
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(a) The PSH model
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(b) The PSH model with time-covariate interactions
The solid line is a locally weighted regression smooth with span= 0.5.
Figure 3: Plots of Shoenfeld-type residuals of the PSH model and the PSH model with
time-covariate interactions.
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with time-covariate interactions.
Figure 4: Predicted cumulative incidences of locoreginal recurrence for two subgroups defined
by Zi = (treatment, surgery type, age, tumor size).
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2.5 DISCUSSION
In this study, we propose a risk prediction modeling procedure to accurately estimate the
cumulative incidence function for data with competing risks. The proposed methods are
robust, simple to implement, not sensitive to the proportional subdistribution hazards as-
sumption, and can incorporate multiple discrete and continuous prognostic factors without
the need to test the model fit.
In the simulation studies, we compared cross-validated prediction errors and found that
our proposed stopped PSH model has the same prediction accuracy as that obtained from
the nonparametric estimates if all covariates are discrete; and it has the same prediction
accuracy as the PSH model with time-covariate interactions when the functional form of
time was correctly specified. Using real data from a breast cancer clinical trial, it illustrated
that the proposed approach is straightforward and simple to implement for risk prediction.
As compared with the PSH model with time-covariate interactions, our stopped PSH model
has another appealing advantage that is it does not require modeling the functional forms of
time-varying effects. Although the Schoenfeld-type residuals could be utilized to represent
and test the functional forms, if the functional form is incorrectly specified, the residuals
would have little use and the goodness-of-fit testing procedure would become less powerful
[36]. There may also be concerned about the issue of overfitting if adding time-covariate
interactions increases the number of parameters. As shown in our simulations, in the first
non-PSH setting, adding time-covariate interactions may not capture all nonproportionality
effects. In this situation, we found that the goodness-of-fit tests and the modeling procedure
allowing time-covariate interactions into the PSH model are not applicable.
Our proposed models might be less efficient in some situations. As opposed to the PSH
model which uses information over the entire follow-up period, the stopped PSH model uses
information only up to the prediction horizon time. Therefore, the stopped PSH model
might be less efficient than the PSH model at the early follow-up period. Also, if the cen-
soring proportion is low prior to the horizon time, the nonparametric estimates of censoring
probabilities could be less efficient. As a result, the weights derived from these censoring
probabilities would yield unreliable results in the weighted stopped PSH model.
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In estimation of the Brier score with the traditional method, one often uses the IPCW
to deal with censoring. This approach could lead to biased estimates if the number of main
events is low and the censoring percentage is high. An alternative strategy is to use the
pseudo-observation approach to deal with high percent of censoring [5]. Moreover, if the
number of main events is small, the cross-validation strategy is not effective. In this case,
it is preferred to validate the performance of the models using an external dataset which is
independent of the dataset used for fitting the model.
The proposed methods allow the users to predict the CIF at a given horizon time therefore
can be used for risk stratification or therapy assignments. If a researcher’s goal is to find
the absolute risk of a specific event, our procedure is more attractive and less complex than
the currently available models. However, our proposed models do not serve the purpose of
estimating a covariate effect or capturing the overall trajectory of the effect through time.
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3.0 LANDMARK PROPORTIONAL SUBDISTRIBUTION HAZARDS
MODELS FOR DYNAMIC PREDICTION OF CUMULATIVE INCIDENCE
PROBABILITIES
3.1 INTRODUCTION
A patient’s baseline prognosis predicted at the moment of diagnosis or at the beginning of
treatment often changes over time with the progression of disease. Patients who share similar
baseline prognosis could have very different prognosis at later time points during follow-up
because of population heterogeneity. In such cases, prognosis performed at the baseline are
unable to reveal the underlying dynamic changes. Prognosis tools that can update patients’
prognosis dynamically using information collected during follow-up about disease progression
will be more helpful to patients and clinicians in their decision-making [4, 17].
A dynamic prediction refers to dynamically predicting a patient’s prognosis at later
time points during follow-up by incorporating all the time-dependent prognostic information
collected up to the time points. The time-dependent information includes the potential
time-varying covariate effects, i.e. the effect of some prognostic factors may diminish as
time elapses from diagnosis, the intermediate clinical events, i.e. the occurrence of acute
graft versus host disease (aGvHD) for acute lymphoid leukemia patients after bone marrow
transplantation, and the longitudinally measured biomarkers, i.e. CD4 cell count for HIV
patients and prostate-specific antigen (PSA) level for prostate cancer patients.
The quantities of primary interest in dynamic prediction are conditional survival proba-
bility for data containing no competing risks and conditional cause-specific cumulative inci-
dence function for data with competing risks [31, 33]. The conditional survival probability
is defined as the probability of surviving beyond a pre-specified time (the prediction horizon
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time, thor) or surviving an additional w-years given that the patient is still alive at certain
specified time points (the landmark time, tLM) during follow-up. Similarly, the conditional
cause-specific cumulative incidence function is the probability that the event of interest oc-
curs before thor conditional on the patient who has not yet failed from any cause at tLM . For
those patients who have not experienced any event at tLM , clinicians may predict the risk
by estimating the next w-years cumulative incidence function based on all the prognostic
information available at the landmark time point.
Several statistical methods have been used to incorporate the intermediate clinical events
or the repeated measures of biomarkers in dynamic prediction. Van Houwelingen and Putter
(2008) [32] utilized multi-state models to dynamically estimate the failure free survival during
follow-up of acute lymphoid leukemia patients after transplantation given the history on
aGvHD. Proust-Lima and Taylor (2009) [3] developed a joint modeling approach derived from
a joint latent class model to dynamically predict the risk of recurrence given the longitudinal
posttreatment PSA measures. Mauguen et al. (2013) [18] proposed a dynamic prognostic
tool based on joint frailty models to predict patients’ risk of death given the history on cancer
recurrence.
Although multi-state models and joint models are useful in understanding the underlying
process of a disease progression over time, predictions using either of these two models
are complex and the implementation could be cumbersome. In multi-state models, where
all the intermediate and terminal events are defined as states, each transition from one
state to another need to be modeled separately [22] which could result in overfitting. In
addition, when the Markov assumption is not satisfied in practice, the multi-state models
could not provide explicit expressions for the dynamic prediction probabilities and additional
simulation procedures are needed [9]. The limitation of applying joint models as a dynamic
prognostic tool is the computational complexity in jointly modeling the longitudinal covariate
processes and time-to-event data [3, 33]. Furthermore, developing multi-state models or
joint models for data with various types of time-dependent information will be even more
complicated.
Van Houwelingen (2007) [31] developed a more simple and straightforward dynamic prog-
nostic tool for data containing no competing risks. In contrast to the multi-state models
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and joint modeling approach, the proposed landmark Cox dynamic prediction models can
incorporate time-varying covariate effects, intermediate events, and repeated measurements
of biomarkers simultaneously into one single model that also provides an explicit expression
for the conditional survival probability [31–33]. The landmark method avoids complex pro-
cedures of modeling either the time-varying effects or the longitudinal covariate processes,
thus it is less demanding in computation and easier to implement than other methods of
dynamic prediction.
The landmark method was originally introduced by Anderson et al. (1983) [1] to cor-
rect the immortal time bias in the analysis of survival of ”responders” and ”nonresponders”
in cancer patients to evaluate the effect of response to chemotherapy. The immortal time
bias was introduced when the survival probabilities were compared between ”responders”
and ”nonresponders” from the start of the study, since the patients’ response status was
determined at later time points during follow-up but not at the baseline. This bias leaded
the survival probability to be overestimated for ”responders” but underestimated for ”nonre-
sponders”. The landmark method is applied to patients who are alive at a fixed pre-specified
time point, the landmark, during follow-up with survival analyses conditional on these pa-
tients using their response status measured at the landmark time. All patients who died or
were censored before landmark are excluded from the analysis [1, 7].
Van Houwelingen (2007) [31] applied the landmark method to the Cox proportional
hazards model and proposed the landmark Cox model to dynamically predict the probability
of failure at prediction horizon time thor conditional on the subjects who have not yet failed
at landmark time tLM given the event’s history and the time-dependent covariates until
tLM . The proposed landmark Cox model can also accommodate the time-varying effects,
because it is robust against violation of the proportional hazards assumption. In addition,
van Houwelingen (2007) [31] further developed more comprehensive landmark supermodels
that requires fitting only one model for making dynamic prediction at any landmark point
from a pre-specified interval, instead of fitting a landmark Cox model for each landmark
time point separately.
To extend the landmark dynamic prediction method to data containing competing risks,
Nicolaie et al. (2013) [19] developed landmark supermodels based on the cause-specific
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hazards function. However, in order to estimate the conditional CIFs, this approach requires
fitting the landmark supermodels for all causes of failure separately then combining the
results. Hence, there is a lack of one-to-one correspondence in the interpretation of landmark-
dependent covariate effects on the dynamic predictive probabilities. To directly predict the
conditional CIFs, Nicolaie et al. (2013) [20] proposed landmark supermodels based on the
dynamic pseudo-observations that are updated at each landmark point. Cortese et al. (2013)
[5] applied the landmark method to the Fine-Gray proportional sub-distribution hazards
(PSH) model [8] at a small set of pre-defined fixed time points. However, they did not assess
robustness of their proposed model against violations of the PSH assumption, nor did they
construct a more comprehensive landmark supermodel to reduce complexity in computation
when there are multiple landmark time points of interest. The major difficulty encountered
by other researchers attempting to develop a landmark model/supermodel based on the
Fine-Gray model was in constructing the landmark subset at each landmark time point to
properly deal with the competing events [19].
In this study, we overcame the aforementioned challenges and extended the landmark
approach to the Fine-Gray PSH model for data with competing risks. We proposed a simple
landmark PSH model that can be used to directly predict the conditional CIFs in one step
and will provide simple and accurate prediction of the conditional CIFs for covariates with
possible time-varying effects bypassing complex modeling of the process of time-varying co-
variates effect. We further developed a landmark PSH supermodel which can be used to make
dynamic predictions at arbitrary landmark points by fitting only one model. In addition, we
adopted the concept of sliding prediction window from van Houwelingen and Putter (2012)
[33] and allowed the horizon time to vary. In this case, the landmark PSH models provide a
dynamic prediction tool to estimate conditional CIFs at tLM + w, where w is a fixed width
of the prediction window. Compared to the currently available landmark models for data
containing competing risks, our proposed landmark PSH models are straightforward, easy to
implement and can yield a simpler and explicit estimation form for the desired conditional
CIFs.
In the next section, we introduce the dynamic prediction probabilities in competing
risks, and present our proposed landmark PSH model and landmark PSH supermodels. In
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Section 3.4, we assess the performance in prediction for the proposed models and compare
with the existing methods through simulations. In Section 3.5, we apply the proposed models
to predict the w-year fixed width cumulative incidences of locoregional recurrence given a
set of prognostic factors from a breast cancer clinical trial. The discussions are provided in
Section 3.6.
3.2 DYNAMIC PREDICTION WITH TIME-VARYING COVARIATE
EFFECTS
3.2.1 Conditional Cumulative Incidence Function
In Section 3.2, we only consider time-fixed covariates, but the covariate effects might be
changing over time. The target dynamic prediction probability is the conditional cause-
specific cumulative incidence function that is the cumulative incidence probability of occur-
ring the event of interest by a pre-specified prediction horizon time thor conditional on the
individuals who have not yet failed from any cause at a landmark time point tLM .
Following the same notations introduced in Section 2.2.1, the corresponding conditional
CIF for cause 1 is defined as
F1,LM(thor|Z, tLM) = Pr(T ≤ thor, ε = 1|T > tLM ,Z), (3.1)
where T is the failure time, ε ∈ {1, . . . , k} is the cause of failure, and Z is a p-dimensional
vector of time-fixed covariates. Using the definition of conditional probabilities, we can
rewrite the conditional CIF as
F1,LM(thor|Z, tLM) = F1(thor;Z)− F1(tLM ;Z)
S(tLM ;Z)
=
F1(thor;Z)− F1(tLM ;Z)
1−∑kj=1 Fj(tLM ;Z) ,
where Fj(tLM ;Z) is the CIF for cause j and S(tLM ;Z) is the overall survival at time tLM .
Several methods can be used to estimate F1,LM(thor|Z, tLM), including the nonparamet-
ric estimates, the cause-specific hazards model, the Fine-Gray proportional subdistribution
hazards (PSH) model [8], the multistate model [6], the pseudo-value approach [15], and the
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direct binomial regression model [26]. However, all these methods require at least two steps
in estimating the conditional CIFs; the first step is to estimate the probabilities of having no
event up to the landmark time; and the second step is to estimate the cumulative incidences
of developing the main event between the landmark time and the horizon time. Moreover,
to predict the conditional CIFs at a set of landmark time points using the aforementioned
methods, one has to fit the models separately for each landmark point; which could be com-
putationally cumbersome. In addition, the cause-specific hazards model and the Fine-Gray
model are sensitive to the proportionality assumption which assumes that the covariate ef-
fects are constant over time, yet often the assumption is violated in a long-term follow-up.
Therefore, these methods are not ideal for dynamic prediction when dealing with competing
risks data.
In order to directly estimate the conditional CIF in one step, we generalize the landmark-
ing approach proposed by van Houwelingen (2007) [31] into the Fine-Gray PSH model and
propose a landmark PSH model. The proposed landmark PSH model can also accommodate
the potential time-varying covariate effects because it is robust against the misspecification
of the proportional subdistribution hazards.
3.2.2 Landmark PSH Model
To directly estimate the F1,LM(thor|Z, tLM), we define a conditional subdistribution hazard
λ1(t|Z, tLM) = lim
∆t→0
1
∆t
Pr{t ≤ T ≤ t+ ∆t, ε = 1|T ≥ t ∪ (tLM ≤ T ≤ t ∩ ε 6= 1),Z}
for t ≥ tLM , which is the subdistribution hazards λ1(t|Z) defined in Section 2.2.1 conditional
on the subjects who have no event occurred from any cause prior to tLM . It can be shown
that
F1,LM(thor|Z, tLM) = Pr(tLM < T ≤ thor, ε = 1|Z)/Pr(T > tLM |Z)
= 1− Pr{(T > thor) ∪ (tLM < T ≤ thor ∩ ε 6= 1)|Z}/Pr(T > tLM |Z)
= 1− exp[−{Λ1(thor|Z, tLM)− Λ1(tLM − |Z, tLM)}]
= 1− exp
{
−
∫ thor
tLM
λ1(t|Z, tLM) dt
}
. (3.2)
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Following the form of the PSH model, we define a landmark PSH model which is given
by
λ1(t|Z, tLM) = λ10(t|tLM) exp{ZTβLM} for tLM ≤ t ≤ thor. (3.3)
Therefore, the conditional CIF can be easily computed from Fˆ1,LM(thor|Z, tLM) = 1 −
exp{− ∫ thor
tLM
λˆ1(t|Z, tLM) dt}. The model can be fitted by applying the Fine-Gray PSH model
to the data of individuals who have not failed from any cause at tLM and ignoring the events
occurring after the horizon time thor by adding administrative censoring at thor.
The landmark PSH model with truncation at tLM and administrative censoring at thor
is also robust against violations of the proportional subdistribution hazards assumption.
Under the nonproportionality, based on the results showed Chapter 2, we can derive that
the partial likelihood estimator βˆLM calculated from the landmark PSH model is a weighted
average of the true time-varying effects in the interval [tLM , thor] and the corresponding
Fˆ1,LM(thor|Z, tLM) is an approximately correct estimate for the underlying true conditional
CIF at time thor.
So, the proposed landmark PSH model provides a convenient and straightforward way to
predict the conditional CIF F1,LM(thor|Z, tLM) in one model. In addition, it can incorporate
the potential time-varying covariate effects into dynamic prediction via a simple model form
without constructing complex procedures to model the time-varying effects.
3.2.3 Landmark PSH Supermodel
Different from the fixed horizon time, van Houwelingen and Putter (2012) [33] proposed
the idea of sliding prediction window, which is taking a window with a fixed width of w
and predicting the failure probabilities at thor = tLM + w given that the subjects have
not experienced any event before tLM . The idea of sliding window is the basis of dynamic
prediction. Generalizing this idea to data with competing risks, our aim is to predict the
cumulative probabilities at the next w years conditional on the individuals who are event-free
at a set of landmark time points tLM = s within an interval [s0, sL]. The target conditional
CIF is defined as F1,LM(s+ w|Z, s).
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Applying landmark PSH models to dynamic prediction is less practical because it is
necessary to fit a landmark PSH model for each landmark point separately. We used the
smoothing strategy of van Houwelingen (2007) [31] for the Cox model to develop a landmark
supermodel based on the PSH model. Similar to the landmark Cox model, the landmark
PSH supermodel is also based on an augmented dataset which is constructed as follows:
we first select a set of landmark points s from an interval [s0, sL]; for each s, we create a
landmarking subset by selecting the individuals who have not failed from any cause at s and
adding administrative censoring at s + w for those who have events occur after s + w; and
then stacking all the individual landmarking subsets into a super prediction dataset.
3.2.3.1 Stratified Landmark PSH Supermodel As discussed in Chapter 2, we have
shown that the βˆLM calculated from model (3.3) is consistent for a weighted average of
possibly time-varying effects over the interval [s, s + w]. As discussed in van Houwelingen
(2007) [31], we can also expect the effect of s on βLM(s) in a smooth way and model βLM(s)
as continuous functions of s. Then, we have the stratified landmark PSH supermodel
λ1(t|Z, s, w) = λ10(t|s, w) exp{ZTβLM(s)} for s ≤ t ≤ s+ w, (3.4)
where λ10(t|s, w) is the unspecified baseline subdistribution hazard for each s. For simplicity,
we can fit a linear model for βLM(s), which takes the form
βLM(s) = βLM(s|θ) =
mβ∑
j=1
θjfj(s)
where f(s) is a set of parametric functions of s and θj is a vector of parameters.
Model (3.4) can be fitted by applying a PSH model with landmark-covariate interactions
Z ∗ fj(s) to the stacked dataset with stratification on s. To obtain the consistent estimates,
we impose that any landmark time point s satisfies s + w < τ , where τ is chosen such that
G(τ) > 0 and S(τ) > 0. The consistent estimates of θ can be obtained by maximizing a
pseudo partial log-likelihood
ipl(θ) =
n∑
i=1
I(εi = 1)
( ∑
s:s≤Ti≤s+w
ln
[
exp{ZTi βLM(s|θ)}∑
j∈Rs(Ti) exp{ZTj βLM(s|θ)}
])
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where Rs(Ti) = {j : (Ti ≤ Tj ≤ s + w) ∪ (s < Tj ≤ Ti ∩ εj 6= 1)}. The ipl(θ) is similar as
that shown in van Houwelingen (2007) [31]; the difference is the modified risk sets Rs(Ti).
In the presence of random right censoring, the ipl(θ) need to be modified by including the
IPCW weights. In terms of the counting process, the weighted ipl(θ) takes the form
iplw(θ) =
n∑
i=1
∫ ∞
0
∑
s:s≤t≤s+w
ln
[
exp{ZTi βLM(s|θ)}∑
j ω
s
j (t)Y
s
j (t) exp{ZTj βLM(s|θ)}
]
ωsi (t) dN
s
i (t)
where N si (t) = I(s < Ti ≤ t, εi = 1), Y si (t) = I(t ≤ Ti ≤ s + w) + I(s < Ti < t, εi 6= 1) and
ωsi (t) =
Gˆs(t)
Gˆs(Xi)
I(s < Xi < t, εi 6= 1) + I(t ≤ Xi ≤ s+w), Gˆs(t) is the Kaplan-Meier estimate
of the conditional censoring survival distribution Gs(t) = Pr(C ≥ t|C ≥ s). To obtain the
standard errors for the estimated parameters, a robust sandwich estimator is required to
adjust for the correlation between the risk sets because the same subject is repeatedly used
when we estimate the parameters based on the stacked dataset.
For each stratum s, the Breslow-type estimator of the baseline conditional subdistribution
hazard is
λˆ10(Ti|s, w) = 1∑
j∈Rs(Ti) exp{ZTj βˆLM(s)}
for s ≤ Ti ≤ s+ w. (3.5)
Similarly, in the presence of random right censoring, the Breslow-type estimator need to be
modified by the IPCW weights.
In the implementation, the R function coxph() can be used to fit model (3.4) and also
provide the robust sandwich estimates for the standard errors; but it requires a transforma-
tion for each landmarking subset in the process of constructing the super prediction dataset.
Before stacking the subsets into a big dataset, following the strategy in Geskus (2011) [12],
we need to transform each subset into the counting process style and include time-varying
IPCW weights for the subjects experienced competing events when random right censoring
is also present. We will then construct a new super dataset by stacking all the transformed
subsets together and run the PSH model in coxph() stratified by s.
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3.2.3.2 Proportional Baselines Landmark PSH Supermodel In practice, the limi-
tation of the stratified landmark PSH model is that it estimates the baseline subdsitribution
hazard separately for each landmark point. As the Breslow estimator (3.5) showed, the
dependence of λˆ10(Ti|s, w) on s is through βˆLM(s); so that we can also expect that the
λ10(t|s, w) varies continuously with s. Following the strategy of van Houwelingen (2007)
[31], we can directly model the λ10(t|s, w) as
λ10(t|s, w) = λ10(t) exp{γ(s)}.
This lead to the proportional baselines landmark PSH supermodel (PBLM-PSH supermodel)
λ1(t|Z, s, w) = λ10(t) exp{ZTβLM(s) + γ(s)} (3.6)
for s0 ≤ t ≤ sL + w. Similarly, γ(s) can be fitted as a linear model
γ(s) = γ(s|η) =
mλ10∑
j=1
ηjgj(s),
where g(s) is a set of parametric functions of s and η is a vector of parameters. Note
that g(s) do not need to contain the constant term and have the restriction of gj(s0) = 0
for all j(j = 1, . . . ,mλ10) due to identifiability of the baseline subdistribution hazard, some
discussion as shown in van Houwelingen (2007) [31].
Model (3.6) can still be fitted by applying a PSH model with landmark-covariate inter-
actions Z ∗ fj(s) to the stacked dataset. Instead of stratifying on the landmark point, it
directly fits s as g(s) into model. To consistently estimate the parameters (θ,η), a Breslow
partial log-likelihood is required for tied events. This is because in the stacked dataset, one
subject with event time Ti has ni = #{s : s ≤ Ti ≤ s+w, s ∈ [s0, sL]} repeated observations.
Thus, fitting the model is equivalent to maximizing a different pseudo partial log-likelihood
which is given by
ipl∗(θ,η) =
n∑
i=1
I(εi = 1) ln
[ ∑
s:s≤Ti≤s+w exp{ZTi βLM(s|θ) + γ(s|η)}∑
s:s≤Ti≤s+w
∑
j∈Rs(Ti) exp{ZTj βLM(s|θ) + γ(s|η)}
]
.
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Similarly, in the presence of random right censoring, the ipl∗(θ,η) need to be weighted by
the IPCW weights. In terms of the counting process, the weighted ipl∗(θ,η) takes the form
ipl∗w(θ,η) =
n∑
i=1
∫ ∞
0
ln
[ ∑
s:s≤t≤s+w ω
s
i (t) exp{ZTi βLM(s|θ) + γ(s|η)}∑
s:s≤t≤s+w
∑
j ω
s
j (t)Y
s
j (t) exp{ZTj βLM(s|θ) + γ(s|η)}
]
dN¯i(t),
where N¯i(t) = I(s0 < Ti ≤ t ≤ sL + w, εi = 1). Again, robust estimates of the standard
errors for the estimated parameters can be obtained by using the sandwich procedure.
For complete and censoring complete data, the estimate of λ10(Ti) is given by
λˆ10(Ti) =
#{s : s ≤ Ti ≤ s+ w, εi = 1}∑
s:s≤Ti≤s+w
∑
j∈Rs(Ti) exp{ZTj βˆLM(s) + γˆ(s)}
for s0 ≤ Ti ≤ sL + w (3.7)
and the cumulative subdistribution hazard is estimated by Λˆ10(t) =
∑
(Ti≤t,εi=1) λˆ10(Ti).
When random right censoring exists, Λˆ10(t) takes the form
Λˆ10(t) =
n∑
i=1
∫ t
0
∑
s:s≤u≤s+w ω
s
i (u)∑
s:s≤u≤s+w
∑
j ω
s
j (u)Y
s
j (u) exp{ZTj βLM(s|θ) + γ(s|η)}
dN¯i(u).
Thus, the target dynamic prediction probabilities F1,LM(s + w|Z, s) have a simple and
explicit estimation form, which is given by
Fˆ1,LM(s+ w|Z, s) = 1− exp
[
−eZT βˆLM (s)+γˆ(s){Λˆ10(s+ w)− Λˆ10(s−)}
]
(3.8)
for all s ∈ [s0, sL]. Compared to model (3.4) which can only get the prediction for the
pre-specified landmark points because the baseline subdistribution hazard is specific for
each s, the proportional baselines landmark PSH supermodel can provide the prediction of
F1,LM(s + w|Z, s) in any period of length w starting anywhere in [s0, sL]. Note that model
(3.6) assume that the effect of s on the baseline subdistribution hazard in an additive way.
As discussed in van Houwelingen (2007) [31], this assumption hold if the follow-up is not too
long or the effect of covariates is not too big. So, if we choose an optimal width w for the
prediction window and a rational range [s0, sL] for the landmark points, according to the
robustness of the PSH model, the proportional baselines landmark PSH supermodel directly
provides a correct approximation for the conditional cumulative incidence function at time
s+ w for any s ∈ [s0, sL].
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In practice, fitting the PBLM-PSH supermodel in the stacked dataset requires software
that allows for delayed entry or left truncation at s. Following the same data transformation
strategies we mentioned before, the coxph() can be still used; and the provided robust sand-
wich covariance matrix for (θ,η) can be used for the significance testing of the estimated
regression coefficients. As we discussed before, the landmark effect on the baseline subdis-
tribution hazard is through βLM(s), so that there is a correlation between θ and η. Van
Houwelingen (2007) [31] suggested to center the covariates, so that the correlation would be
reduced.
3.2.4 Measure of Predictive Accuracy
To evaluate the dynamic predictive accuracy of the proposed procedures, we adapted the
time-dependent Brier score which is an estimate of the mean-squared prediction errors of the
predicted event probabilities at thor = s+w over the observed event status for subjects who
are still alive at landmark s [5, 28]. For competing risks data, the expected time-dependent
Brier score at landmark s for the prediction at horizon thor is defined as
BSLM(thor, s) = E
[{I(T ≤ thor, ε = 1)− F1,LM(thor|Z, s)}2|T > s] ,
where thor > s. For complete data, BSLM(thor, s) can be consistently estimated by
B̂SLM(thor, s) =
1
ns
∑
i∈Rs
{I(Ti ≤ thor, εi = 1)− Fˆ1,LM(thor|Zi, s)}2,
where Rs = {i : Ti > s} and ns is the number of subjects in Rs. When random right
censoring exists, we utilize a pseudovalue-based consistent estimator of BSLM(thor, s), which
was proposed by Cortese et al. (2013) [5]
B̂SLM(thor, s) =
1
n˜s
∑
i∈R˜s
[
Qˆ
(i)
1,LM(thor|s){1− 2Fˆ1,LM(thor|Zi, s)}+ Fˆ1,LM(thor|Zi, s)2
]
,
where R˜s = {i : Xi > s} and n˜s is the number of subjects in R˜s. Qˆ(i)1,LM(thor|s) is a jackknife
pseudovalue for ith subject who is still alive at s, which is defined by
Qˆ
(i)
1,LM(thor|s) = n˜sFˆ1,LM(thor|s)− (n˜s − 1)Fˆ (i)1,LM(thor|s),
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where Fˆ1,LM(thor|s) is the nonparametric estimate of the conditional cumulative incidence
function Pr(T ≤ thor,  = 1|T > s) and Fˆ (i)1,LM(thor|s) is the same estimate but based on the
data where the ith subject has been removed.
3.3 DYNAMIC PREDICTION WITH TIME-DEPENDENT COVARIATES
3.3.1 Landmark PSH Supermodel
When there are time-dependent covariates that may be the occurrence of intermediate events
and/or repeated measurements of biomarkers, the clinical interest is in the dynamic predic-
tion of cumulative incidences given the covariates history available up to the landmark time
point s. The target conditional CIF is defined as
F1,LM(s+ w|Z(s), s) = Pr(T ≤ s+ w, ε = 1|T > s,Z(s)),
where Z(s) include the time-fixed covariates measured at baseline and the time-dependent
covariates whose values are fixed at landmark time s.
To incorporate time-dependent covariates and time-varying covariate effects simultane-
ously, the landmark PSH supermodels provide a simpler way in dynamic prediction for data
with competing risks. The stratified landmark PSH supermodel becomes
λ1(t|Z(s), s, w) = λ10(t|s, w) exp{Z(s)TβLM(s)} for s ≤ t ≤ s+ w, (3.9)
where βLM(s) is also a continuous function of s, can be modeled as βLM(s) = f(s)θ. The
parameter β can be consistently estimated by maximizing
ipl(θ) =
n∑
i=1
I(εi = 1)
( ∑
s:s≤Ti≤s+w
ln
[
exp{Zi(s)TβLM(s|θ)}∑
j∈Rs(Ti) exp{Zj(s)TβLM(s|θ)}
])
.
The estimate of the landmark-specific baseline conditional subdistribution hazards λ10(t|s, w)
is given by
λˆ10(Ti|s, w) = 1∑
j∈Rs(Ti) exp{Zj(s)T βˆLM(s)}
for s ≤ Ti ≤ s+ w.
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As before, we can assume multiplicative effects of landmark s on λ10(t|s, w) and have the
proportional baseline landmark PSH supermodel
λ1(t|Z(s), s, w) = λ10(t) exp{Z(s)TβLM(s) + γ(s)} (3.10)
for s0 ≤ t ≤ sL + w, where βLM(s) = f(s)θ and γ(s) = g(s)η. The consistent estimates of
the parameters (θ,η) can be obtained by maximizing
ipl∗(θ,η) =
n∑
i=1
I(εi = 1) ln
[ ∑
s:s≤Ti≤s+w exp{Zi(s)TβLM(s|θ) + γ(s|η)}∑
s:s≤Ti≤s+w
∑
j∈Rs(Ti) exp{Zj(s)TβLM(s|θ) + γ(s|η)}
]
.
The estimate of λ10(Ti) is given by
λˆ10(Ti) =
#{s : s ≤ Ti ≤ s+ w, εi = 1}∑
s:s≤Ti≤s+w
∑
j∈Rs(Ti) exp{Zj(s)T βˆLM(s) + γˆ(s)}
for s0 ≤ Ti ≤ sL + w.
Thus, the conditional CIF F1,LM(s+ w|Z(s), s) has a simple estimation form
Fˆ1,LM(s+ w|Z(s), s) = 1− exp
[
−eZ(s)T βˆLM (s)+γˆ(s){Λˆ10(s+ w)− Λˆ10(s−)}
]
for all s ∈ [s0, sL].
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3.3.2 Adjusted Landmark PSH Supermodel
In the landmark PSH supmermodel 3.9 and 3.10, we assume that the Markov property is
held where the distribution of the future depends only on the current value, and we use Z(s)
as a proxy for the true value of Z(t). But, if the Z(t) is changing rapidly over time, the big
variation between Z(s) and Z(t) might cause an attenuated covariate effects βLM(s) and
subsequently provide bias estimation of the conditional CIF.
To adjust for this issue, we can explore a set of suitable landmark points to postulate
the process of Z(t) and model the attenuation process. Van Houwelingen and Putter (2012)
[33] proposed a simple method to adjust the attenuated covariate effects by adding a mono-
tonically decreasing function ϕ(t − s) with ϕ(0) = 1 to ϕ(∞) = 0. Utilizing this strategy,
the stratified landmark PSH supermodel can be modified as
λ1(t|Z(s), s, w) = λ10(t|s, w) exp{Z(s)T (βLM(s) ∗ ϕ(t− s))} for s ≤ t ≤ s+ w, (3.11)
where ∗ denotes coordinate-wise multiplication. Similarly, the PBLM-PSH supermodel can
also be adjusted. As a note, to fit the adjusted landmark PSH supermodels, when con-
struct the super stacked dataset, at each landmark-specific subset, we need to expand each
individual’s record at each combinition of landmark point s and event time t.
3.4 SIMULATION STUDIES
We evaluated the performance of the proposed methods for dynamic prediction using sim-
ulated data under two different settings of nonproportional subdistribution hazards (non-
PSH). The time-dependent Brier scores were compared among the proposed landmark PSH
model, the landmark PSH supermodel, the nonparametric method, and the standard PSH
model. For simplicity, only two failure types were considered: type 1 failure is the main
event of interest; type 2 failure indicates competing events.
In the first non-PSH setting, we generated the type 1 failure times from a two-parameter
Weibull mixture distribution with the subdistribution function
F1,1stnonPSH(t;Zi) = p(1− exp[−{λ1 exp(Ziβ1)t}α1 ])
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with (α1, λ1, β1) = (3.2, 0.18,−0.81), where the rate parameter depends on the covariate Zi.
In the second non-PSH setting, we let the coefficient of Zi be a function of time; and the
subdistribution of the main event became
F1,2ndnonPSH(t;Zi) = 1− (1− p[1− exp{−(λ2t)α2}])exp{Ziβ21+Ziβ22 ln(t+1)}
with (α2, λ2, β21, β22) = (3.2, 0.12, 0.8, 0.3). In both settings, we considered Zi as a discrete
covariate from Bernoulli(0.5), and let p = 0.3, which produced about 30% main events
at Zi = 0 when there was no censoring. We generated the type 2 failure times from an
exponential distribution Pr(Ti ≤ t|εi = 2, Zi) = 1 − exp{− exp(Ziβct)} by taking Pr(εi =
2|Zi) = 1 − Pr(εi = 1|Zi), where βc = 0.5. Sample size of n = 1000 was chosen and the
data were simulated repeatedly for N = 1000 times. The censoring times were generated
independently from a uniform distribution which resulted in about 20% censoring.
The performance of the proposed landmark PSH model and the landmark PSH super-
model in dynamic prediction of the conditional CIFs using a fixed width of w at a set of
landmark points were compared with the performance of nonparametric method and the
standard PSH model. We chose a prediction window of width w = 3 for the first non-PSH
setting and w = 2 for the second non-PSH setting. For fitting the landmark PSH super-
model, we set up a fine grid of landmark points with equidistant step of 0.1 from 0 to 5 for
the first non-PSH setting and from 0 to 4 for the second non-PSH setting. In both settings,
we took ordinary polynomials for the basis functions as f(s) = {1, s, s2} and g(s) = {s, s2}.
Since the performance of the stratified landmark PSH supermodel is as good as that of the
proportional baselines landmark supermodel (PBLM-PSH supermodel), we only present the
simulation results of the PBLM-PSH supermodel in this section. Note that the landmark
PSH supermodel in absence of censoring cannot be fitted using the coxph() function in
R, because that the competing risks data cannot be transformed into the counting process
format if there is no censoring; and that the model cannot be fitted by the crr() function in
R either since crr() does not allow delayed entries. Therefore, we only fitted our landmark
PSH model (LM-PSH model) in complete cases. Figure 3.4 depicts the true and estimated
conditional cumulative incidence probabilities obtained from different approaches. We found
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that in two different non-PSH scenarios, the performance of the landmark PSH model and
the PBLM-PSH supermodel are as good as that of the nonparametric methods.
For each approach we evaluated the prediction errors in the dynamic conditional CIFs by
estimating time-dependent Brier scores, and we used a 3-fold cross-validation to correct for
possible overfitting. Table 4 shows averaged estimates of the cross-validated time-dependent
Brier score and its empirical standard deviation. To quantify the improvement of predic-
tive accuracy for the proposed landmark PSH models to the standard PSH model under
nonproportional hazards, we utilized a relative increment (or reduction) of prediction errors
by treating the nonparametric estimates as a reference. The relative increment of predic-
tion errors are presented in Figure 6. As expected, in both non-PSH settings the predictive
accuracy of the LM-PSH model was almost the same as that obtained from the nonpara-
metric method. As compared with the LM-PSH model or the nonparametric method, the
PBLM-PSH supermodel has slightly lower accuracy, yet the differences in prediction errors
are negligible.
Table 4: Cross-validated (3-fold) estimates for the time-dependent Brier score and its em-
pirical standard deviation (SD).
(a) 1st non-PSH setting: prediction window with fixed width of w = 3
Landmark NP PSH LM-PSH PBLM-PSH
tLM Censoring Ave. SD Ave. SD Ave. SD Ave. SD
0 0 2.059 0.430 2.087 0.441 2.074 0.434
20% 2.058 0.470 2.066 0.474 2.058 0.470 2.076 0.476
1 0 4.065 0.498 4.323 0.554 4.116 0.504
20% 6.986 0.889 7.126 0.923 6.986 0.889 7.093 0.909
2 0 5.182 0.411 6.124 0.500 5.271 0.423
20% 12.529 0.854 13.207 0.897 12.529 0.854 12.818 0.934
3 0 4.678 0.406 6.405 0.385 4.790 0.427
20% 14.211 1.104 15.512 0.882 14.212 1.104 14.666 1.238
4 0 3.525 0.448 5.556 0.356 3.624 0.467
20% 12.700 1.820 14.054 1.513 12.707 1.819 13.233 1.939
5 0 2.775 0.409 4.424 0.331 2.851 0.423
20% 11.338 2.269 12.082 2.055 11.356 2.270 12.043 2.441
43
(b) 2nd non-PSH setting: prediction window with fixed width of w = 2
Landmark NP PSH LM-PSH PBLM-PSH
tLM Censoring Ave. SD Ave. SD Ave. SD Ave. SD
0 0 0.639 0.253 0.640 0.253 0.643 0.255
20% 0.640 0.270 0.641 0.271 0.640 0.270 0.646 0.273
1 0 2.257 0.456 2.275 0.462 2.282 0.461
20% 3.536 0.792 3.550 0.796 3.536 0.792 3.579 0.802
2 0 4.662 0.522 4.797 0.543 4.731 0.535
20% 10.078 1.247 10.211 1.257 10.078 1.247 10.253 1.277
3 0 6.326 0.452 7.003 0.453 6.451 0.477
20% 17.716 1.271 18.642 1.181 17.718 1.271 18.180 1.407
4 0 4.739 0.457 7.100 0.344 4.859 0.477
20% 17.713 1.751 21.588 1.323 17.127 1.750 17.936 1.983
NP: the nonparametric method; PSH: the standard PSH model; LM-PSH: the landmark PSH
model; PBLM-PSH: the proportional baselines landmark PSH supermodel. All entries are
multiplyed by 100.
3.5 APPLICATION
3.5.1 Application 1
To illustrate the use of our proposed landmark PSH supermodel in prediction of the con-
ditional cumulative incidence probabilities for a moving (or dynamic) time interval with
fixed width, we used the data from the NSABP B-20 trial which was a multicenter phase
III clinical trial for women with estrogen receptor positive and historically nodes-negative
primary breast cancer. In this trial, 2,363 patients were randomly selected to receive one
of the following three regimens: tamoxifen 10mg daily for 5 years, tamoxifen 10mg daily
for 5 years plus Metrotrexate (M) and Fluorouracil (F), and tamoxifen 10mg daily for 5
years plus M and F, and Cyclophosphamide (C). For simplicity, we will call these treatments
as TAM, TAM+MF, and TAM+CMF, respectively. Among the 2,272 clinically eligible pa-
tients followed up, 119 developed locoregional recurrence (LRR); 482 had other events before
LRR, including distant recurrence, second primary cancers, and death; and the remaining
1,671 were censored. The median follow-up time was 11.2 years. Our main interest in this
application is to dynamically predict the conditional cumulative incidence of LRR for the
subsequent w years given no event occurred before the landmark time point s. Prognostic
44
Table 4 continued
0 1 2 3 4 5
0.0
0.2
0.4
0.6
0.8
1.
0
Time of Landmark
Co
nd
itio
na
l C
IF
 (w
=3
)
1st non−PSH setting
0% Censoring
Z=1
Z=0
True
NP
PSH
LM−PSH
0 1 2 3 4 5
0.0
0.2
0.4
0.6
0.8
1.
0
Time of Landmark
Co
nd
itio
na
l C
IF
 (w
=3
)
1st non−PSH setting
20% Censoring
Z=1
Z=0
True
NP
PSH
LM−PSH
PBLM−PSH
0 1 2 3 4
0.0
0.2
0.4
0.6
0.8
1.
0
Time of Landmark
Co
nd
itio
na
l C
IF
 (w
=2
)
2nd non−PSH setting
0% Censoring
Z=1
Z=0
True
NP
PSH
LM−PSH
0 1 2 3 4
0.0
0.2
0.4
0.6
0.8
1.
0
Time of Landmark
Co
nd
itio
na
l C
IF
 (w
=2
)
2nd non−PSH setting
20% Censoring
Z=1
Z=0
True
NP
PSH
LM−PSH
PBLM−PSH
Black curves: the Z = 1 group; gray curves: the Z = 0 group. True: underlying true conditional
CIFs. NP: nonparametric method; PSH: the standard PSH model; LM-PSH; the landmark PSH
model; PBLM-PSH: the proportional baselines landmark PSH supermodel.
Figure 5: Predicted conditional cumulative incidence functions over w years (averaged over
1000 simulations) at a set of landmark time points.
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The prediction errors were cross-validated (3-fold) estimates for the time-dependent Brier scores,
where w = 3 for the 1st non-PSH setting and w = 2 for the 2nd non-PSH setting. NP:
nonparametric method; PSH: the standard PSH model; LM-PSH; the landmark PSH model;
PBLM-PSH: the proportional baselines landmark PSH supermodel.
Figure 6: Relative increment of prediction errors (and their standard deviation) at a set of
landmark time points.
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covariates of interest include the treatment type (TAM, TAM+MF, or TAM+CMF), surgery
type (lumpectomy plus radiation therapy [L+XRT] vs. mastectomy), age at the study entry
(< 50 vs. ≥ 50 years old), clinical tumor size (≤ 2 vs. > 2 cm), and tumor grade (well,
moderate, and poor). All covariates were measured at the baseline.
Figure 7(a) and 7(b) shows that the estimated cumulative incidence of LRR is stable
after 12 years (i.e., only a few LRR events occurred); and that few random censoring events
occurred during the first 10-year of follow-up. Therefore, we set up a grid of landmark
time points from 0 to 8 years and chose the prediction interval of width w = 2. To fit a
proportional baselines landmark PSH (PBLM-PSH) supermodel to this dataset, we took 41
equally space landmark points s (0 ≤ s ≤ 8) and set the basis functions for βLM(s) and
γ(s) as βLM(s) = θ1 + θ2s+ θ3s
2 and γ(s) = η1s+ η2s
2, respectively. The frequency of LRR
in each of the landmark sub-dataset for s = 0, 1, . . . , 8 years are shown in Figure 7(c) for
illustration.
We began our analysis by selecting covariates which effects are dependent on the land-
mark points using the backward selection procedure. We tested the landmark-covariate
interactions for each covariate using the Wald test based on the robust covariance matrix
of the estimated coefficients from the PBLM-PSH supermodel. We found that only the
effect of tumor grade (poor vs. well) are significantly dependent on the landmark points
(χ2[2] = 6.76, p = 0.034). Effects of other covariates do not deviate significantly from time-
invariant effects. The effect of treatment TAM+MF is not significantly different from that of
the treatment TAM. The effects of well and moderate tumor grade on the incident LRR are
almost undifferentiable. The estimated log subdistribution hazard ratio and its correspond-
ing robust standard error for a given prognostic factor are reported in Table 5. Multivariate
Wald test for the baseline parameters (η1, η2) is significant (χ
2
[2] = 8.59, p = 0.014), indicating
that the baseline subdistribution hazard is also dependent on the choice of landmark points.
Figure 8(a) shows the comparison between the estimated log subdistribution hazards
ratio and the associated pointwise 95% confidence intervals for patients with poorly differ-
entiated tumor and those with well differentiated tumor adjusting for other covariates. As
shown in the figure, the effect of tumor grade (poor vs. well) decreases over the landmark
time from s = 0 on, and becomes stable after s = 5 years. The subdistribution hazard ratio
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of poor to well tumor grade changes from 3.58(= exp(1.28)) at the beginning of the follow-up
to 0.74(= exp(−0.30)) at year 5. The risk effect of poor tumor grade is diminishing over
time of landmarking. This result is in line with many breast cancer studies which reported
an attenuated prognostic effect of tumor grade as follow-up progressed. We also graphically
examined the estimated landmark-dependent effect of tumor grade and the 95% confidence
intervals obtained from the landmark PSH model (figure not shown). We found that the
curves from these two different landmark PSH models are almost identical, which indicates
that the landmark PSH supermodel can provide a good smoothing on the landmark effect.
Figure 8(b) and 8(c) demonstrate the estimated cumulative baseline subdistribution hazard
Λˆ10(t) and the estimated landmark effect on the baseline subdistribution hazard. Along with
the increase of s, exp(γˆ(s)) rises rapidly at the beginning then slows down, and decreases
in the right tail. The right-tail decreasing could be explained by that patients with better
prognosis are more likely to be included in the landmark subset for the landmark time points
close to 8 years.
For each level of tumor grades (poor, moderate, and well) and for each treatment group
(TAM, TAM+MF, or TAM+CMF), Figure 9 depicts the predicted dynamic 2-year fixed
width cumulative incidences of LRR for patients younger than 50 years old with tumor
larger than 2cm and were receiving L+XRT. In all three treatment groups, we found similar
patterns of dynamic predictive cumulative incidence over the landmark time changing from
0 to 8 years between the moderately differentiated tumor group and the well differentiated
tumor group. In contrast, patients with poorly differentiated tumor grade had apparently
higher risks of LRR for the subsequent 2 years of the given landmark time (less than 3.5 years
from baseline), especially for those who received TAM or TAM+MF. There is a higher risk of
LRR shown at the beginning of follow-up for patients with poorly differentiated tumor grade;
yet if they survive for about one and half years, their 2-year cumulative incidence of LRR
decreased dramatically. After 3.5 years from the baseline, patients with poorly differentiated
tumor grade had similar 2-year risk of LRR as those with moderate and well differentiated
tumor grades. This indicates that the effect of tumor grade is insignificant for those patients
who are still alive or who have not failed from any cause up to the landmark points that are
after 3.5 years.
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Table 5: Estimated regression parameters of the proportional baselines landmark PSH su-
permodel for locoregional recurrence.
Time Parameter Robust
Covariate function estimate standard error
TAM + MF vs. TAM Constant -0.258 0.222
TAM + CMF vs. TAM Constant -1.305 0.307
Age (≥ 50 vs. < 50) Constant -0.780 0.210
Mastectomy vs. L + XRT Constant -0.521 0.210
Clinical tumor size (> 2 vs. ≤ 2 cm) Constant 0.620 0.213
Tumor grade (moderate vs. well) Constant -0.216 0.251
Tumor grade (poor vs. well) Constant 1.275 0.469
s -0.515 0.300
s2 0.040 0.038
Baseline parameters
η1 s 0.229 0.121
η2 s
2 -0.017 0.013
3.5.2 Application 2
In this application example, we used the same data set as the one used in previous Section
3.5.1. But, at this time, the main event of interest is distant metastasis, and death is
competing events. For early stage breast cancer patients who received surgery, development
of locoregional recurrence (LRR) is an important prognostic clinical event affecting the risk
of distant metastasis. Therefore, we treat LRR as intermediate clinical event to dynamically
predict the risk of distant metastasis within the subsequent 3-years for a breast cancer
patient, based on her LRR status measured during follow-up and other prognostic covariates
measured at baseline. We also compared the dynamic 3-year fixed width probabilities of
distant metastasis and death based on a patients LRR history.
Among the 2,272 clinically eligible patients followed up, 241 developed distant metastasis,
127 died due to other causes before distant metastasis could occur, and the remaining 1,904
were censored. In this data, 17.8% of the patients developed LRR before progressing to
distant metastasis; but only 7.1% patients experienced LRR before death. Figure 10(a)
shows that both the estimated cumulative incident distant metastasis and the estimated
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mortality rates are stable after 13 years (i.e., few events occurred). Figure 10(b) depicts the
estimated distribution of LRR. Only a few random censoring events occurred during the first
10 years of follow-up (figure not shown). We chose the range of landmark points from 0 to 10
years and prediction window with a fixed width of 3-years. To fit a PBLM-PSH supermodel
to this dataset, we took 51 equally spaced landmark points s (0 ≤ s ≤ 10) and set the
basis functions for βLM(s) and γ(s) as βLM(s) = θ1 + θ2s + θ3s
2 and γ(s) = η1s + η2s
2,
respectively. The frequencies of distant metastasis and death in each of the landmark sub-
dataset for s = 0, 1, . . . , 10 years are shown in Figure 10(c).
We began our analysis using the backward selection procedure to select those covariates
the effects of which were dependent on the landmark points. We tested the landmark-
covariate interactions for each covariate via the Wald test based on the robust covariance
matrix of the estimated coefficients from the PBLM-PSH supermodel. We found that for
distant metastasis, the effects of TAM+MR and age are significantly dependent on the
landmark points, whereas for death, only the effect of LRR status is dependent on the
landmark points. The estimated coefficient and the corresponding robust standard error for
a given prognostic factor are summarized in Table 6. Multivariate Wald tests for the baseline
parameters (η1, η2) are significant for both distant metastasis and death, indicating that the
baseline subdistribution hazard also depends on the choice of landmark points.
For different locoregional recurrence status (no LRR developed over the course of study,
with LRR occurred at 3, 5, and 7 years) and for each treatment group (TAM, TAM+MF,
or TAM+CMF), Figure 11 depicts the predicted dynamic 3-year fixed width cumulative
incidences and the associated bootstrap 95% confidence intervals of distant metastasis and
death for a patient 50 years old or younger with poorly differentiated tumor, size larger than
2cm and were receiving L+XRT. If the patient did not have a LRR, her risk of having distant
metastasis within the subsequent 3 years is very close to the risk of death for any treatment
group. However, if the patient had a LRR, she had a much higher risk of distant metastasis
as compared to the risk of death, especially for TAM+MF treatment group. Similar results
were obtained for patients who experienced LRR at 3, 5, and 7 years, respectively.
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3.6 DISCUSSION
In this study, we developed dynamic predictive models for data containing competing risks
by extending the landmark approach to the Fine-Gray PSH model. The resulting landmark
PSH models can be used to directly predict the dynamic cumulative incidences of failure
for a specific cause within a given prediction window of a fixed width by incorporating all
available information updated up to this landmark time under the condition that the patient
has not failed at the landmark time.
Our proposed models have several advantages over currently available methods in pre-
dicting conditional CIFs. The first is that our landmark PSH models can provide accu-
rate estimates even when a covariate effect is time-varying (a violation of the PSH as-
sumption), whereas the model developed by Cortese et al. (2013) [5], which also incor-
porates the landmark approach into the Fine-Gray model, will not give an unbiased es-
timate if a covariate in the model violates the PSH assumption. The second advantage
is that unlike the standard Fine-Gray PSH model which does not allow the use of inter-
nal time-dependent covariate for predicting the CIF [2, 14], our proposed landmark PSH
models can incorporate both internal and external time-dependent information through a
simple model form without simultaneously modeling the covariate changing process and
the time-to-event outcome process. The landmark approach can provide simpler explicit
form of estimates and it is much easier to incorporate time-dependent covariates as com-
pared to the multistate models and joint models which are more complicated and prone
to overfitting. Furthermore, our landmark PSH supermodel could be more straightfor-
ward and simpler in implementation using the existing software packages. Being differ-
ent from the landmark supermodel based on the cause-specific hazards [19], our landmark
PSH supermodel predicts the conditional CIFs in one step and provides a direct interpre-
tation of predictive probabilities. In comparison with the landmark supermodel based on
the pseudo-observations [20], our landmark PSH supermodel is simpler in computation,
whereas the GEE-based method used in pseudo-observations would have convergence is-
sues for large sample size especially when dealing with many landmark points of interest.
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Through simulations, we evaluated the prediction performance of our proposed models
and compared them with other existing methods. We determined how closely the estimated
conditional CIFs would approximate the true probabilities for our models, which is the first
of its kind done in this area of study. We further utilized time-dependent Brier score to
assess a model’s discrimination and calibration capabilities simultaneously. The simulation
results showed that our models performed well in prediction even when the PSH assumption
was violated. Although some other studies applied time-dependent ROCs to evaluate their
prediction models [23] we did not choose the same approach because the ROCs and AUCs
can only be used to assess the capability of discrimination not calibration. In the future, we
will use ROC-based method as a tool to evaluate the discriminative accuracy of the marker
for a specific marker of interest.
In application studies, we found that the baseline conditional subdistribution hazard
was significantly dependent on the landmark s through exp(γ(s)). When applying PBLM-
PSH supermodel to other data, it is possible that the baseline subdistribution hazard is
independent of s. In such case, we suggest that one keeps exp(γ(s)) in the model to maintain
coherence; more discussions on this topic can be found in van Houwelingen (2007) [31]. If
there are too many covariates significantly dependent on the landmark time point, it is better
to reduce the dimension by combining covariates into a prognostic index before fitting the
landmark PSH supermodel.
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Figure 7: Descriptive analysis of the NSABP B-20 data.
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Figure 8: Regression results from the PBLM-PSH supermodel.
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Figure 9: The esimated 2-year fixed width predictive cumulative incidences of locoregional
recurrence for patients younger than 50-years old with tumor larger than 2cm and treated
with L + XRT, in each of the treatment groups (TAM, TAM + MF, TAM + CMF) and
different levels of tumor grade.
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Table 6: Estimated regression parameters of the proportional baseline landmark PSH super-
model for distant metastasis and death.
Distant metastasis Death
Covariate βˆ SE(βˆ) βˆ SE(βˆ)
TAM + MF vs. TAM Constant -1.091 0.331 -0.312 0.238
s 0.482 0.160
s2 -0.050 0.017
TAM + CMF vs. TAM Constant -0.470 0.170 0.160 0.219
Age (≥ 50 vs. < 50) Constant -0.540 0.257 1.057 0.218
s 0.407 0.135
s2 -0.035 0.015
Mastectomy vs. L + XRT Constant 0.424 0.144 -0.115 0.189
Clinical tumor size (> 2 vs. ≤ 2 cm) Constant 0.284 0.141 0.334 0.196
Tumor grade (moderate vs. well) Constant 0.221 0.179 0.104 0.221
Tumor grade (poor vs. well) Constant 0.752 0.189 0.124 0.258
Local-regional recurrence status Constant 2.315 0.237 3.575 1.230
s -0.492 0.582
s2 0.008 0.056
Baseline parameters
η1 s -0.400 0.088 -0.001 0.014
η2 s
2 0.035 0.009 0.002 0.001
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Figure 10: Descriptive analysis of the B-20 data in application 2
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Figure 11: The predicted 3-year fixed width cumulative incidences of distant metastasis
(solid lines), death (dashed lines) and associated 95% confidence intervals (shaded areas)
for different landmark time points, for a patient younger than 50-tears old with poor tumor
grade, tumor larger than 2cm and treated with lumpectomy, for each of the treatment groups
and with locoregional recurrence occurred at none, 3 years, 5 years and 7 years.
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APPENDIX A
ANDERSEN-GILL-TYPE CONDITIONS
Following Xu and O’Quigley (2000) [35], we define w(t) = S(t)/E{I(X ≥ t)}, which is
a non-negative bounded function uniformly in t. Here, we assume that there is enough
information on F1(t) in the tails in the presence of censoring.
Andersen-Gill-type conditions:
A. (Finite interval).
∫ 1
0
λ10(t)dt <∞.
B. (Asymptotic stability). There exists a neighbourhood B of β such that 0 and β(t), in
which t ∈ [0, 1], are in the interior of B, and for r = 0, 1, 2
sup
t∈[0,1]
|S(r)(β(t), t)− s(r)(β(t), t)| P−→ 0,
sup
t∈[0,1]
|S(r)(β, t)− s(r)(β, t)| P−→ 0, sup
t∈[0,1]
|nW (t)− w(t)| P−→ 0.
C. (Lindeberg condition). There exists δ > 0 such that
n−1/2 sup
i,t
|Zi|Yi(t)I{ZTi β(t) > −δ|Zi|} P−→ 0,
n1/2 sup
i,t
W (t)|Zi|Yi(t)I{ZTi β(t) > −δnW (t)|Zi|} P−→ 0.
D. (Asymptotic regularity conditions). All (deterministic) functions in B are uniformly
continuous in t ∈ [0, 1]; s(r), r = 0, 1, 2, are continuous functions of β ∈ B, and are
bounded on B × [0, 1]; s(0)(β(t), t) and s(0)(β, t) are bounded away from zero. For all
β ∈ B, t ∈ [0, 1], s(1)(β, t) = ∂
∂β
s(0)(β, t), s(2)(β, t) = ∂
2
∂β2
s(0)(β, t).
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APPENDIX B
DERIVATION OF THE APPROXIMATION (2.12) IN CHAPTER 2
Let λˆ10(β(t), t) be the Breslow estimator of the baseline subdistribution hazard under a
coorect model specification, and λˆ10(β(t), t) is consistent for the true value λ10(t). The
λˆ10(t) is the Breslow estimator calculated from the model using arbitrary β, and λˆ10(t)
converges in probability to a limiting value λ∗10(t).
Following the same derivations in van Houwelingen (2007) [31], we have
λˆ10(β(t), t)
λˆ10(t)
=
S(0)(t,β)
S(0)(t,β(t))
p→ s
(0)(t,β)
s(0)(t,β(t))
=
s
(0)
∗ (t,β)
s
(0)
∗ (t,β(t))
.
As in the deviation of equation (2.5), under random right censoring, it can be shown that
s
(0)
∗ (t,β)
s
(0)
∗ (t,β(t))
= E
[
exp{ZT (β∗hor − β(t))}|T ∗ = t
]
≈ exp [E(Z|T ∗ = t)T{β∗hor − β(t)}] . (B.1)
Under the assumption that the β(t) does not vary too much over time, the approxima-
tion (2.12) can be derived from (B.1), given by
λ∗10(t) ≈ λ10(t) exp[E(Z|T ∗ = t)T{β(t)− β∗hor}].
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